You have 0 free disease views remaining today. Register for more view, it is 100% free →
gastroesophageal adenocarcinoma
Description
Gastroesophageal Adenocarcinoma (EAC) Description
Gastroesophageal adenocarcinoma (EAC) is a type of cancer that affects the glandular cells of the lower esophagus, specifically at the junction with the stomach. It is a sub-type of esophageal carcinoma (EC), which is a rare and aggressive form of cancer.
Characteristics
- EAC is characterized by the growth of malignant differentiated glandular tumor proliferation in the esophagus.
- The center of the tumor is located more than 1 cm from the squamocolumnar junction, which is the area where the esophagus meets the stomach.
- This type of cancer is often associated with a poor prognosis and limited treatment options.
Incidence
- EAC is the most common subtype of esophageal cancer in the United States.
- The incidence of EAC has risen dramatically in recent years, making it an important public health concern.
Symptoms
- Pain in the throat or back, behind the breastbone or between the shoulder blades.
- Vomiting or coughing up blood are also common symptoms of esophageal cancer, including EAC.
References
- [1] Esophageal adenocarcinoma is defined as malignant differentiated glandular tumor proliferation of the esophagus, the center of which is located more than 1 cm from the squamocolumnar junction. (Source: #2)
- EAC is a sub-type of esophageal carcinoma (EC) affecting the glandular cells of the lower esophagus at the junction with the stomach. (Source: #4)
- Esophageal adenocarcinoma is the most common subtype of esophageal cancer in the United States, and its incidence has risen dramatically in recent years. (Source: #6)
- Cancer of the esophagus starts when cells in the lining of the esophagus begin to grow out of control, which can lead to symptoms such as pain and vomiting. (Source: #7)
Additional Characteristics
- Characteristics
- Gastroesophageal adenocarcinoma (EAC) is a type of cancer that affects the glandular cells of the lower esophagus, specifically at the junction with the stomach.
- The center of the tumor is located more than 1 cm from the squamocolumnar junction, which is the area where the esophagus meets the stomach.
- EAC is the most common subtype of esophageal cancer in the United States.
- Esophageal adenocarcinoma is the most common subtype of esophageal cancer in the United States, and its incidence has risen dramatically in recent years.
- Esophageal adenocarcinoma is defined as malignant differentiated glandular tumor proliferation of the esophagus, the center of which is located more than 1 cm from the squamocolumnar junction.
Signs and Symptoms
Gastroesophageal adenocarcinoma, also known as esophageal cancer, can be a serious condition if left untreated. The signs and symptoms of this disease can vary from person to person, but here are some common ones:
- Trouble swallowing: This is the most common symptom of esophageal cancer, where food gets stuck in the throat or chest, making it difficult to swallow solids or liquids [1][2][4].
- Chest pain: Pain or pressure in the chest, which can be a sharp or dull ache, is another common symptom [1][3][5].
- Weight loss: Unintentional weight loss, often accompanied by a decrease in appetite, can also be a sign of esophageal cancer [2][4][8].
- Hoarseness: A persistent cough or hoarseness can be an early warning sign of this disease [1][3][5].
- Vomiting blood: In some cases, vomiting blood (hematemesis) or coughing up blood (hemoptysis) can occur due to the tumor's growth and invasion into surrounding tissues [6][7].
It's essential to note that these symptoms can also be caused by other conditions, so a proper diagnosis from a healthcare professional is necessary for an accurate assessment.
References: [1] - Context result 1: "Symptoms · Difficulty swallowing. · Chest pain, pressure or burning. · Coughing or hoarseness." [2] - Context result 2: "Signs and Symptoms of Esophageal Cancer · Trouble swallowing · Chest pain · Weight loss" [3] - Context result 5: "What are the symptoms of esophageal cancer? · Trouble Swallowing · Chronic Chest Pain · Weight Loss Without Trying" [4] - Context result 4: "Early symptoms of esophageal cancer: Trouble swallowing. This is the most common and easily recognizable symptom..." [5] - Context result 5: "What are the symptoms of esophageal cancer? · Trouble Swallowing · Chronic Chest Pain · Weight Loss Without Trying" [6] - Context result 7: "Vomiting blood (hematemesis) · Coughing up blood (hemoptysis)" [7] - Context result 8: "Esophageal Cancer Symptoms · Difficulty or pain when you swallow, which is the most common symptom · Weight loss..." [8] - Context result 9: "What does esophageal cancer feel like? · Loss of appetite · Pain, pressure or burning sensations in the chest"
Additional Symptoms
- Trouble swallowing
- Vomiting blood
- weight loss
- chest pain
- hoarseness
Diagnostic Tests
Diagnostic Tests for Gastroesophageal Adenocarcinoma
Gastroesophageal adenocarcinoma, a type of cancer that affects the esophagus and stomach, requires accurate diagnosis to determine the best course of treatment. Various diagnostic tests can help identify this condition.
- Imaging Tests: These are often used as the first line of investigation to look for signs of gastroesophageal adenocarcinoma. The following imaging tests may be employed:
- X-rays: Can show abnormalities in the esophagus or stomach, but are not typically used for detailed examination [3].
- CT (Computed Tomography) scans: Provide more detailed images of the internal organs and can help identify tumors or other abnormalities [3].
- MRI (Magnetic Resonance Imaging) scans: May be used to get a better view of the esophagus and stomach, especially if there are concerns about the spread of cancer [3].
- PET (Positron Emission Tomography) scans: Can help determine if the cancer has spread to other parts of the body [3].
- Endoscopy: This is considered the gold standard for diagnosing gastroesophageal adenocarcinoma. An endoscope, a thin flexible tube with a camera and light on the end, is passed through the mouth into the esophagus and stomach to visually inspect these areas [4]. A biopsy (removing a small sample of tissue) can be taken during this procedure for further examination.
- Upper Endoscopy: This specific type of endoscopy is often used to diagnose gastroesophageal adenocarcinoma. It involves passing an upper endoscope through the mouth into the esophagus and stomach, while the patient is sedated [1].
- Endoscopic Ultrasound (EUS): Can provide detailed images of the esophagus and surrounding tissues, helping determine the size and spread of tumors [6].
Other Diagnostic Methods
In addition to these tests, other methods may be used in conjunction with endoscopy or as part of a comprehensive diagnostic approach:
- Blood Chemistry Studies: May help identify any metabolic changes associated with cancer.
- Complete Blood Count (CBC): Can show if there are any abnormalities in the blood that could indicate cancer.
It's worth noting that while these tests can aid in diagnosis, no standard or routine screening test exists for gastroesophageal adenocarcinoma [5]. Early detection and accurate diagnosis are crucial for effective treatment and management of this condition.
Additional Diagnostic Tests
- Imaging Tests
- Complete Blood Count (CBC)
- Endoscopic Ultrasound (EUS)
- Endoscopy
- Upper Endoscopy
- Blood Chemistry Studies
Treatment
Treatment Options for Gastroesophageal Adenocarcinoma
Gastroesophageal adenocarcinoma is a type of cancer that affects the esophagus and stomach. The treatment options for this condition are varied and depend on several factors, including the stage of cancer, overall health, and personal preferences.
Chemotherapy
Chemotherapy is one of the most common treatments for gastroesophageal adenocarcinoma. It involves using strong medicines to kill cancer cells. Chemotherapy can be used before or after surgery in people with localized disease (1). The most common chemotherapy agents used for esophageal cancer include alkylating, antimetabolite, anthracycline, and antimicrotubular agents (6).
Targeted Therapy
Targeted therapy is a type of treatment that uses medicines to specifically target cancer cells. For gastroesophageal adenocarcinoma, targeted therapies such as HER2-targeted therapy may be used (3). These treatments work by targeting specific proteins on the surface of cancer cells.
Immunotherapy
Immunotherapy is another type of treatment that uses the body's immune system to fight cancer. For gastroesophageal adenocarcinoma, immunotherapies such as checkpoint inhibitors may be used (3).
Lonsurf (Trifluridine/Tipiracil)
Lonsurf (trifluridine/tipiracil) is a medication that may be used to treat recurrent or metastatic adenocarcinoma tumors at the gastroesophageal junction. It is typically used after other treatments have failed (5).
Other Treatments
In addition to chemotherapy, targeted therapy, and immunotherapy, other treatments such as surgery, radiotherapy, chemoradiotherapy, and supportive care may also be used to manage symptoms and improve quality of life.
References:
- [1] Apr 15, 2024 — Drugs Approved for Gastroesophageal Junction Cancer
- [3] by JJ Li · 2023 · Cited by 2 — Current FDA approved treatments include HER2-targeted therapy, immunotherapy, and chemotherapy.
- [5] Lonsurf (trifluridine/tipiracil) may be used to treat recurrent or metastatic adenocarcinoma tumours at the gastroesophageal (GE) junction.
- [6] Nov 2, 2024 — Most chemotherapy agents that are currently used for the treatment of esophageal cancer, including alkylating, antimetabolite, anthracycline, and antimicrotubular agents.
Recommended Medications
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Supportive care
- Surgery
- Radiotherapy
- Chemoradiotherapy
- Tipiracil)
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Differential Diagnoses for Gastroesophageal Adenocarcinoma
Gastroesophageal adenocarcinoma, a type of esophageal cancer, can be challenging to diagnose due to its similarity in symptoms with other conditions. Here are some differential diagnoses that should be considered:
- GERD (Gastroesophageal Reflux Disease): GERD is a common condition characterized by the reflux of stomach acid into the esophagus, causing symptoms such as heartburn and dysphagia [4].
- Esophageal Stricture: An esophageal stricture is a narrowing of the esophagus that can cause difficulty swallowing (dysphagia) [1].
- Achalasia: Achalasia is a rare condition characterized by the inability of food to pass through the esophagus due to muscle spasms, leading to symptoms such as dysphagia and regurgitation [1].
- Gastric Lymphoma: Gastric lymphoma is a type of cancer that affects the stomach lining and can cause symptoms similar to gastroesophageal adenocarcinoma, including abdominal pain and weight loss [8].
- Gastric Metastasis: Gastric metastasis refers to the spread of cancer from another part of the body (such as the breast or colon) to the stomach, which can cause symptoms such as abdominal pain and weight loss [8].
It's essential to note that these differential diagnoses are not exhaustive, and a thorough medical evaluation is necessary to determine the correct diagnosis.
References:
[1] Esophageal lesions other than cancer that can cause dysphagia include achalasia, esophageal stricture from gastroesophageal reflux disease [context 1] [4] Esophageal adenocarcinoma must be differentiated from other causes of dysphagia, odynophagia and food regurgitation such as GERD [context 4] [8] The imaging differential can be broad and includes gastric lymphoma, gastric metastasis [context 8]
Additional Differential Diagnoses
- Esophageal Stricture
- Gastric Metastasis
- achalasia
- gastric lymphoma
- gastroesophageal reflux disease
Additional Information
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:0080375
- core#notation
- DOID:0080375
- IAO_0000115
- A gastroesophageal cancer that has_material_basis_in abnormally proliferating cells, derives_from epithelial cells, which originate in glandular tissue.
- oboInOwl#hasExactSynonym
- gastro-esophageal adenocarcinoma
- rdf-schema#label
- gastroesophageal adenocarcinoma
- rdf-schema#subClassOf
- http://purl.obolibrary.org/obo/DOID_4944
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_2744
- owl#annotatedSource
- t353524
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.